Experimental Three-Hormone Drug Produced Major Weight Loss in Trial
In a Lilly-funded phase 2 trial, adults with obesity who received the highest dose of retatrutide lost an average of 24.2% of their body weight over 48 weeks. The results…
In a Lilly-funded phase 2 trial, adults with obesity who received the highest dose of retatrutide lost an average of 24.2% of their body weight over 48 weeks. The results…